Ignite Creation Date:
2025-12-24 @ 11:48 AM
Ignite Modification Date:
2025-12-30 @ 6:10 PM
Study NCT ID:
NCT05528861
Status:
TERMINATED
Last Update Posted:
2024-09-27
First Post:
2022-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous Urticaria
Sponsor:
Allakos Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AK002-027
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None